Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 780 clinical trials
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection

Purpose of Study The purpose of this study to evaluate, the effectiveness of convalescent plasma in combatting the symptoms and effects of the coronavirus disease, COVID-19. Beyond supportive care, there are no proven treatment options for COVID-19.

SARS
acute respiratory syndrome (sars)
covid-19
FIO2
d-dimer
  • 0 views
  • 05 Aug, 2020
  • 0 views
  • 05 Aug, 2020
Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital

  • To identify patients with higher risk of deep venous thrombosis.
  • ul>

    deep vein thrombosis
    thrombosis
    covid-19
    • 0 views
    • 16 Feb, 2024
    • 1 location
    Mucopolysaccharidosis I (MPS I) Registry

    The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients receiving enzyme replacement therapy, such as Aldurazyme (Recombinant Human Alpha-L-Iduronidase), or other treatment modalities.

    The objectives of the Registry …

    • 0 views
    • 04 Dec, 2020
    • 125 locations
    Pompe Disease Registry

    ul>

    gaa gene
    myozyme
    glycogen storage disease type ii
    replacement therapy
    deficiency
    • 0 views
    • 22 Dec, 2020
    • 169 locations
    • 0 views
    • 08 Dec, 2023
    • 16 locations
    Use of PCR-Sars-CoV-2 in Children

    This algorithm, in two parts, can be used, when symptoms are detected in children, to orient and guide :

    <ul>
  • first, parents and community personnel to recognize the signs of infection call signs that should involve medical consultation;
  • but also, the physicians who will carry out this …

    acute respiratory syndrome (sars)
    SARS
    • 0 views
    • 16 Feb, 2024
    • 2 locations
    International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

  • To evaluate the long-term effectiveness of imiglucerase and of eliglustat.
  • ul>

    Gaucher Pregnancy Sub-registry: The primary objective of this Sub-registry is to track pregnancy outcomes, including complications and infant growth, in all women with Gaucher disease during pregnancy, regardless of whether they receive disease-specific therapy.

    eliglustat
    gaucher disease
    imiglucerase
    deficiency
    • 0 views
    • 04 Dec, 2020
    • 209 locations
    Fabry Disease Registry & Pregnancy Sub-registry

    No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.

    The primary objectives of the Registry are:
    <ul>
  • To enhance the understanding of the variability, progression, and natural history of Fabry disease, including heterozygous females with the …

    fabry's disease
    agalsidase beta
    fabrazyme
    replacement therapy
    alpha-galactosidase
    • 0 views
    • 22 Dec, 2020
    • 126 locations
    Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer

  • To identify factors associated with the risk of death and morbidity among patients with cancer. Methodology
  • ul>

    Retrospective inclusion of n=200 cancer patients hospitalized for COVID and n=400 matched (based on age, gender, and comorbidity) non-cancer patients hospitalized for COVID.

    • 0 views
    • 16 Feb, 2024
    • 5 locations